First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience

Randomized phase III trials have shown significant improvement of survival 1, 2, and 3 years after implantation of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) wafers for patients with newly diagnosed malignant glioma. But these studies and subsequent non-phase III studies have also shown risks asso...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bock, Hans Christoph, Puchner, Maximilian Josef Anton, Lohmann, Frauke, Schütze, Michael, Koll, Simone, Ketter, Ralf, Buchalla, Ruediger, Rainov, Nikolai, Kantelhardt, Sven R., Rohde, Veit, Giese, Alf
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2936684/
https://ncbi.nlm.nih.gov/pubmed/20706757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10143-010-0280-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados